MedTrace Logo

Otitis Treatment With OtoSight™ - Modification of Antibiotic Treatment Intervention in Children

NCT06285812 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 700

Last updated 2026-05-12

No results posted yet for this study

Summary

A pragmatic, mixed-method trial is to show the ability of OtoSight to change management of the pediatric patient presenting with ear pain in a way that improves patient outcomes and reduces costs.

Conditions

  • Otitis Media Acute

Interventions

DEVICE

OtoSight Middle Ear Scope

Subjects will be evaluated with the OtoSight Middle Ear Scope

Sponsors & Collaborators

  • TTi Health Research & Economics

    collaborator UNKNOWN

  • PhotoniCare, Inc.

    lead INDUSTRY

Eligibility

Min Age
6 Months
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-10
Primary Completion
2026-06-30
Completion
2026-07-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06285812 on ClinicalTrials.gov